Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vumerity in East Asian adults with relapsing multiple sclerosis
CTR20221451Phase 3Completed
- Sponsor
- Biogen
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diroximel fumarate in multiple sclerosis (MS), sponsored by Biogen. Started Jun 2022; status: completed.
02
Drugs
diroximel fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20221451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221451.